欧洲监管者建议扩大使用GlaxoSmithKline的癌症药物Jemperli, European regulators recommend expanded use of GlaxoSmithKline's cancer drug Jemperli for endometrial cancer.

GlaxoSmithKline的癌症药物Jemperli收到了欧洲医药署的积极建议,要求扩大治疗内地癌症的使用范围。 GlaxoSmithKline's cancer drug Jemperli has received a positive recommendation from the European Medicines Agency for expanded use in treating endometrial cancer. 这项建议使该药物在欧洲更接近于获得市场批准,预计明年初将作出决定。 This recommendation brings the drug closer to gaining marketing approval in Europe, with a decision expected early next year. 美国食品药品管理局也承认Jemperli是一种突破性治疗。 The U.S. FDA has also recognized Jemperli as a breakthrough therapy.